APA (7th ed.) Citation

Siegel, A. B., Cohen, E. I., Ocean, A., Lehrer, D., Goldenberg, A., Knox, J. J., . . . Schwartz, J. D. (2008). Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. Journal of clinical oncology, 26(18), 2992. https://doi.org/10.1200/JCO.2007.15.9947

Chicago Style (17th ed.) Citation

Siegel, Abby B., et al. "Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma." Journal of Clinical Oncology 26, no. 18 (2008): 2992. https://doi.org/10.1200/JCO.2007.15.9947.

MLA (9th ed.) Citation

Siegel, Abby B., et al. "Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma." Journal of Clinical Oncology, vol. 26, no. 18, 2008, p. 2992, https://doi.org/10.1200/JCO.2007.15.9947.